Type 1 Diabetes Intervention Trial Results a Mixed Bag.
"We’re testing things in new-onset type 1 diabetes to see whether or not they modify the course of the disease, and to gain insights as to which ones are safe enough to take into prevention studies. ... The field is in a state of flux at the moment," (Dr. Jay S. Skyler). Marian E. Tucker. Internal Medicine News. 06/30/11. (Also see: Diabetes Treatments)
These items were posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Type 1 Diabetes Intervention Trial Results a Mixed Bag
No replies to this topic